By Karen Blum
With 31 biosimilar products approved by the FDA in the United States to date, the agents are slowly gaining a foothold, according to a presentation at the ASHP 2021 Midyear Clinical Meeting and Exhibition, held virtually. But significant market penetration is still available.
DECEMBER 9, 2021